SB 9200: Phase IIa started

Spring Bank began the double-blind, placebo-controlled, international Phase IIa ACHIEVE trial to evaluate 25, 50, 100 or 200 mg SB 9200 for 12 weeks followed by Viread tenofovir disoproxil fumarate m...